MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Climb Bio (CLYM) Ownership - Who owns Climb Bio?

Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
20 William Street
Phone
+1 866 857-2596
Employees
29
Web
https://www.climbbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
591.02M
P/E Ratio
-12.55
Total Cash
183.12M
Projected Growth
N/A
Total Debt
1.31M
Revenue
N/A
Risk (Beta)
-0.14
Dividend Yield
N/A
Total Cash/Share
3.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
CLYM
Alerts
Alerts
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for CLYM
Related Blogs
CNXU

Conexeu Sciences (CNXU): Is a Recovery to $5.00 Realistic?

PRQR

ProQR Therapeutics (PRQR): Examining Its RNA Editing Platform and Lilly Collaboration

ARWR

Why Is Arrowhead Pharmaceuticals (ARWR) Stock Down -13.53% Today?

OKUR

OnKure Therapeutics (OKUR): A Precision Oncology Play Centered on PI3Kα Inhibition

IKT

Why Is Inhibikase Therapeutics (IKT) Stock Down -6.55% Today?

View all blogs related to
#Biotechnology
Interesting Articles

What is a Variable Annuity?

What is the Risk/Return Trade-Off

What are the basics of technical analysis?

What Is Infrastructure?

What are Credit Score Ranges? What They Mean for Borrowers?

View all articles
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
20 William Street
Phone
+1 866 857-2596
Employees
29
Web
https://www.climbbio.com
Who owns Climb Bio? CLYM symbol Ownership - Tickeron.com